INTERNATIONAL PATENT: SCHEER, MATHIAS JOSEF, EMOVIAR PHARMACON GMBH FILES APPLICATION FOR "SUSTAINED RELEASE DOSAGE FORM FOR LOW SOLUBILITY COMPOUND AXITINIB, IBRUTINIB AND/OR PALBOCICLIB AND METHODS FOR PREPARING OF THIS SUSTAINED RELEASE DOSAGE FORM"

GENEVA, April 27 -- SCHEER, Mathias Josef (MerianstraBe 5379664 Wehr), EMOVIAR PHARMACON GMBH (MerianstraBe 5379664 Wehr) filed a patent application (PCT/EP2025/079646) for "SUSTAINED RELEASE DOSAGE FORM FOR LOW SOLUBILITY COMPOUND AXITINIB, IBRUTINIB AND/OR PALBOCICLIB AND METHODS FOR PREPARING OF THIS SUSTAINED RELEASE DOSAGE FORM" on Oct 14, 2025. With publication no. WO/2026/082741, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NARVEKAR, Himank (MerianstraBe 5379664 Wehr)

Abstract: The present invention relates to ...